Top Markets
Coin of the day
Sangui Biotech International, Inc. Sangui Biotech International, Inc.

Sangui Biotech International, Inc.

SGBI
Rankning i aktier #41117
Sangui Biotech International, Inc., through its subsidiary Sangui BioTech GmbH,... Sangui Biotech International, Inc., through its subsidiary Sangui BioTech GmbH, specializes in creating artificial oxygen carriers derived from hemoglobin. These innovative products are utilized as blood supplements, blood volume replacements, and various related formulations. The company's oxygen carriers are vital for delivering oxygen to humans experiencing acute or chronic oxygen deprivation due to conditions like blocked arteries, anemia, or blood loss, as well as for managing chronic wounds. Their product line also includes nano-formulations designed for skin regeneration, enhancing moisture and elasticity. Furthermore, they provide Chitoskin wound pads to aid in healing and Hemospray, a medical-grade spray specifically formulated for treating persistent wounds. The wound spray products, marketed under the Granulox brand, are primarily distributed in Europe and Mexico, while their cosmetic items are available through an online store. Established in 1995, Sangui Biotech International, Inc. is based in Hamburg, Germany.
Aktiekurs
$0.0002
Senast synkroniserad: 2025-07-02
Marknadsvärde
$41.98K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
DE
Handel Sangui Biotech International, Inc. (SGBI)

Kategori

EPS för Sangui Biotech International, Inc. (SGBI)
EPS per 2026 TTM: 0
Enligt Sangui Biotech International, Inc.s senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) 0. Vid slutet av 2026 hade bolaget ett EPS på 0, lika med EPS från 2026 som var 0.
EPS-historik för Sangui Biotech International, Inc. från 2026 till 2026
EPS vid slutet av varje år
År EPS Ändra
Inte tillräckligt med data för de angivna datumen.
EPS för liknande företag eller konkurrenter